Affronti, Mary Lou https://orcid.org/0000-0003-4004-7834
Lee, Jiyeon
Molassiotis, Alex
Johnson, Lindsay
Tinianov, Stacey
Clark-Snow, Rebecca
Scotte, Florian
Article History
Received: 10 April 2024
Accepted: 3 May 2024
First Online: 10 May 2024
Declarations
:
: This did not require an ethical approval or consent.
: Not applicable. No images or identifying information of human subjects were included in the publication.
: Dr. Mary L. Affronti received funding from TeSera to conduct an investigator-initiated Phase II Study, is member of the MASCC Antiemetic study group and on the 2023 Antiemetic Guideline Consensus Committee (Chairs the Patient Antiemetic Guideline committee; Member of Integrative/Nonpharmological Antiemetic Guideline committee) without financial compensation. Dr. Affronti is on the 2023 Society for Neuro-Oncology serving as Board Directors and receives no financial compensation.